U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
BIWA-4 MERTANSINE
Preferred Name English
BIVATUZUMAB MERTANSINE
INN  
INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD44V6 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL BIWA4 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL BIWA4 .KAPPA.-CHAIN, DIMER, MERTANSINE CONJUGATE
Systematic Name English
Code System Code Type Description
CAS
936332-86-4
Created by admin on Wed Apr 02 07:50:20 GMT 2025 , Edited by admin on Wed Apr 02 07:50:20 GMT 2025
PRIMARY
FDA UNII
074GT4PR9D
Created by admin on Wed Apr 02 07:50:20 GMT 2025 , Edited by admin on Wed Apr 02 07:50:20 GMT 2025
PRIMARY
INN
7965
Created by admin on Wed Apr 02 07:50:20 GMT 2025 , Edited by admin on Wed Apr 02 07:50:20 GMT 2025
PRIMARY
EVMPD
SUB20327
Created by admin on Wed Apr 02 07:50:20 GMT 2025 , Edited by admin on Wed Apr 02 07:50:20 GMT 2025
PRIMARY
SMS_ID
100000175008
Created by admin on Wed Apr 02 07:50:20 GMT 2025 , Edited by admin on Wed Apr 02 07:50:20 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108413
Created by admin on Wed Apr 02 07:50:20 GMT 2025 , Edited by admin on Wed Apr 02 07:50:20 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966